Results 191 to 200 of about 43,362 (258)
The Emerging Parkinson's Disease Oxylipin‐Ome
ABSTRACT Parkinson Disease (PD) is increasingly considered a proteinopathy and lipidopathy. This proteinopathy+lipidopathy paradigm has been further refined to a fatty acid (FA)‐opathy, centering dysregulated FA metabolism as fundamental in PD lipid dysfunction.
Julia C. Kelliher, Saranna Fanning
wiley +1 more source
EEG network reorganization across Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies. [PDF]
Benussi A +6 more
europepmc +1 more source
Emerging directions in tauopathy research
Abstract The Tau Global Conference 2025, hosted by the Alzheimer's Association, CurePSP, and the Rainwater Charitable Foundation, convened international experts from academia, industry, government, and philanthropy to explore advances and challenges in tauopathy research. The meeting highlighted progress across tau biology, including emerging models of
Luc Buée +41 more
wiley +1 more source
Discriminative Plasma Lipidomic Signatures of Dementia with Lewy Bodies and Alzheimer's Disease: A Targeted Mass Spectrometry and Machine Learning Approach. [PDF]
Wen L +5 more
europepmc +1 more source
Abstract Informal caregivers are central to dementia care in Latin America and the Caribbean (LAC), yet determinants of caregiver burden remain insufficiently characterized. We conducted a systematic review and meta‐analysis of studies examining patient‐ and caregiver‐related correlates of burden in LAC.
Paula Quintero‐Cardona +5 more
wiley +1 more source
Alpha-synuclein seeding activity in postmortem tissues from patients with diffuse and isolated Lewy bodies. [PDF]
Baranová S +4 more
europepmc +1 more source
Abstract Since 2016, the Alzheimer's Association and the Fondation Alzheimer have hosted Global Alzheimer's Leadership Series (GoALS) global think tanks, with world‐leading experts for innovative discussions to advance Alzheimer's disease (AD) research and care.
Philippe Amouyel +26 more
wiley +1 more source
Theta burst stimulation for depressive symptoms in early-stage dementia with Lewy bodies: Protocol for a single-arm open-label feasibility study (DL-TBS Study). [PDF]
Takahashi S +5 more
europepmc +1 more source

